Cargando…
Optimal Androgen Deprivation Therapy Combined with Proton Beam Therapy for Prostate Cancer: Results from a Multi-Institutional Study of the Japanese Radiation Oncology Study Group
Background: Androgen deprivation therapy (ADT) combined with radiation therapy benefits intermediate- and high-risk prostate cancer (PC) patients. The optimal ADT duration in combination with high-dose proton beam therapy (PBT) remains unknown. Methods: Intermediate- and high-risk PC patients treate...
Autores principales: | Murakami, Motohiro, Ishikawa, Hitoshi, Shimizu, Shosei, Iwata, Hiromitsu, Okimoto, Tomoaki, Takagi, Masaru, Murayama, Shigeyuki, Akimoto, Tetsuo, Wada, Hitoshi, Arimura, Takeshi, Sato, Yoshitaka, Gosho, Masahiko, Nakamura, Katsumasa, Sakurai, Hideyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352923/ https://www.ncbi.nlm.nih.gov/pubmed/32630494 http://dx.doi.org/10.3390/cancers12061690 |
Ejemplares similares
-
Long‐term outcomes of proton therapy for prostate cancer in Japan: a multi‐institutional survey of the Japanese Radiation Oncology Study Group
por: Iwata, Hiromitsu, et al.
Publicado: (2018) -
Multi-Institutional Retrospective Analysis of the Outcomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary Cancers
por: Aibe, Norihiro, et al.
Publicado: (2021) -
Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan
por: Demizu, Yusuke, et al.
Publicado: (2017) -
Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
por: Utsumi, Takanobu, et al.
Publicado: (2023) -
Particle therapy for prostate cancer: The past, present and future
por: Ishikawa, Hitoshi, et al.
Publicado: (2019)